Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Axiron
Pharma
AbbVie nears settlement covering 4,000-plus AndroGel cases
AndroGel plaintiffs and drugmaker AbbVie have progressed in settlement talks, and a judge stayed further proceedings so they can work out a deal.
Eric Sagonowsky
Sep 11, 2018 10:35am
AndroGel trial do-over slashes AbbVie damages to $3M
Mar 27, 2018 11:05am
Judge overturns $150M AndroGel verdict against AbbVie
Dec 29, 2017 2:06pm
Judge limits suit against 'low-T' drugs but lets it go to trial
May 17, 2017 10:05am
AbbVie's AndroGel faces more questions about heart risks
Feb 21, 2017 11:09am
